 |
| Run Silent, run deep! |
True, while other counters involved in palm oil oleins took flight, SAB being the dullard, stayed put at it price level. Out of a few hundred days of trading this year, apparently it traded less than 80 days.
So illiquid are its holdings that the company was asked at its AGM today, whether there are reasons why the trade is so thin.
Are there other possible reasons for keeping the price low?
A possible privatisation?
And what about that piece of land sitting on the border of Kota Kemuning. Is it going for a revaluation?
Even now, at the current asset base, SAB would fetch an NTA of above RM3.00?
The Chairman was also asked questions on why they are keeping their health division if their focus is on oleo-chemicals and possibly plantations. They have bought plantation in Indonesia and at Lahad Datu in Sabah. also, Are there going to put up a oleo-chemical plant in Indonesia which will cost SAB, RM500 million?
As usual, most of the questions were deflected.
So, what do you think?
Will SAB's price be re-rated now that there is this possibility of asset revaluation or will it not take place so that their price can be kept low for a privatisation move?
Your guess is as bad or as good as mine.
Door price-quite a fancy China mug (Body count basis), a full RM510 superior medical checkup package at Sinar Kota Medical Center and a sumptuous international buffet lunch at the Grand Dorsett's Coffee House in Subang Jaya.
